Glaucomaweek – timeline

When the answer to "How are you?" isn't honestly "Fine," it's time for some honest reflection. Visit our Physician Wellness site to learn what we can do to help those who look after our health. ow.ly/XUmq50BBMdm #mentalhealth #wellbeing #suicideprevention

test Twitter Media - When the answer to "How are you?" isn't honestly "Fine," it's time for some honest reflection. Visit our Physician Wellness site to learn what we can do to help those who look after our health. https://t.co/amIKmKKhYP #mentalhealth #wellbeing #suicideprevention https://t.co/lJ0JofwYox

Machine-learning algorithms could help predict course of NPDR, according to results of a new study. #diabetes #diabeticretinopathy #ophthalmology buff.ly/3hQcOoC

test Twitter Media - Machine-learning algorithms could help predict course of NPDR, according to results of a new study. #diabetes #diabeticretinopathy #ophthalmology  https://t.co/JQ4CURYMgi https://t.co/PuFyZwTqbW

Are posterior corneal curvature changes culprit in hyperopic shifts? #ophthalmology buff.ly/33K1Uvy

test Twitter Media - Are posterior corneal curvature changes culprit in hyperopic shifts? #ophthalmology  https://t.co/VL7ofY4xpt https://t.co/zsMhbutyES

Growing cyclosporine options pose challenges, advantages in treating dry eye patients, @LisaNijmMDJD explains. #ophthalmology #dryeye buff.ly/32Ol2ZY

test Twitter Media - Growing cyclosporine options pose challenges, advantages in treating dry eye patients, @LisaNijmMDJD explains. #ophthalmology #dryeye https://t.co/G33AzDroQI https://t.co/JMfhzHhyXd

Don't miss the digital edition of our Sept. 15 issue! Check it out here: buff.ly/3cABNve #ophthalmology

test Twitter Media - Don't miss the digital edition of our Sept. 15 issue! Check it out here: https://t.co/UYQXYj5Rzn #ophthalmology https://t.co/xc5wUvVWfH

Learn how researchers grew functional retinal organoids in a dish, tocilizumab shows promise for #covid19 and more, in a new #WeekinReview: ow.ly/ZdjM50BBsLX

WATCH: 2020 VISION: pharma representatives share their outlook on what lies ahead for glaucoma innovations within the ophthalmic space @belkin @allerganeye @SantenUSA #ophthalmology buff.ly/330H0cE

ICYMI via #Glaucoma360: Glaucoma drug delivery devices enter new frontier buff.ly/35TNHih

test Twitter Media - ICYMI via #Glaucoma360: Glaucoma drug delivery devices enter new frontier https://t.co/3XdlERArbK https://t.co/veSE08EZOH

An ophthalmologist facing down #COVID19 finds a silver lining in his diagnosis buff.ly/33K1Eg4

test Twitter Media - An ophthalmologist facing down #COVID19 finds a silver lining in his diagnosis https://t.co/dL0ju9VXAx https://t.co/Cp5pLipSAA

Physicians’ treatment decisions are reinforced with good data @OphthTimes buff.ly/2Yj6sXJ

test Twitter Media - Physicians’ treatment decisions are reinforced with good data @OphthTimes 
https://t.co/jc1Pofy8BK https://t.co/x6IMh8wzQg

Keep your eyes healthy while you’re keeping in touch. Please visit lght.ly/eg8iifa for information and top tips while using screens #EyeWeek Please visit lght.ly/jfn0l1d to view our #NEHW video.

test Twitter Media - Keep your eyes healthy while you’re keeping in touch. Please visit https://t.co/wXJ8zeRyJd for information and top tips while using screens #EyeWeek

Please visit https://t.co/vjDaPyb2jw to view our #NEHW video. https://t.co/KCJsNC2b7c

Ready to learn the latest in glaucoma? Check out our #AAO2020 #Virtual programming and register now! ow.ly/L3sk50BAD5W #ophthalmology

test Twitter Media - Ready to learn the latest in glaucoma? Check out our #AAO2020 #Virtual programming and register now! https://t.co/zVikUEGMjQ #ophthalmology https://t.co/hgcfanMXi9

Working out the mystery of ectasia risk with artificial intelligence buff.ly/2ZYpnYR

test Twitter Media - Working out the mystery of ectasia risk with artificial intelligence https://t.co/lsy4ZV4lVY https://t.co/p0lP3kUWka

Earn your CE from home! The full Academy 2020 At Home daily education schedule is now available on our site. What will you attend? Click here to access. bit.ly/3hv7W8i #AAOptometry #Academy20 #CEfromhome

test Twitter Media - Earn your CE from home! The full Academy 2020 At Home daily education schedule is now available on our site. What will you attend? Click here to access. https://t.co/4RbFGBupqe #AAOptometry #Academy20 #CEfromhome https://t.co/vr0oOpFO3h

Minimising risks during routine ophthalmic examinations in the COVID-19 era #ophthalmology #coronavirus buff.ly/34DaPRG

test Twitter Media - Minimising risks during routine ophthalmic examinations in the COVID-19 era #ophthalmology #coronavirus https://t.co/yMRv4QCjFG https://t.co/lEDDmQIcGY

Emerging opportunities — and risks — with telehealth in a pandemic #ophthalmology #coronavirus buff.ly/2YQi4lD

test Twitter Media - Emerging opportunities — and risks — with telehealth in a pandemic #ophthalmology #coronavirus  https://t.co/0A5nK6CJ29 https://t.co/yDX3FEVS22

Researchers: Protocol V findings offer physicians guidance for managing #DME @ARVOinfo #ARVO2020 #ophthalmology buff.ly/3mJjpVI

test Twitter Media - Researchers: Protocol V findings offer physicians guidance for managing #DME @ARVOinfo #ARVO2020 #ophthalmology https://t.co/awECNKOlgg https://t.co/MNGqQdssLr

Our CEO, Karen Osborn, and Gus Gazzard, Consultant Ophthalmic Surgeon at @Moorfields and member of Glaucoma UK’s Clinical Advisory Panel, were on BBC Radio 4's In Touch programme this week answering listeners' questions about glaucoma. Listen to it here: lght.ly/o5m80f6

Item posted March 09, 2017


World Glaucoma Week 2021

countdown to #glaucomaweek in 2021:

gif